EZH2, enhancer of zeste 2 polycomb repressive complex 2 subunit, 2146
N. diseases: 653; N. variants: 35
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 7 | 148807666 | missense variant | T/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 7 | 148809078 | frameshift variant | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||||
|
0.882 | 0.120 | 7 | 148808210 | intron variant | C/T | snv | 0.73 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||||
|
0.882 | 0.120 | 7 | 148808210 | intron variant | C/T | snv | 0.73 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2016 | 2018 | |||||||
|
0.925 | 0.080 | 7 | 148855364 | intron variant | C/T | snv | 0.76 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 7 | 148855364 | intron variant | C/T | snv | 0.76 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.120 | 7 | 148809375 | missense variant | G/C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.120 | 7 | 148809375 | missense variant | G/C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.080 | 7 | 148865843 | intron variant | T/C | snv | 0.41 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 7 | 148865843 | intron variant | T/C | snv | 0.41 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 7 | 148811741 | non coding transcript exon variant | A/C;G;T | snv | 0.67 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
1.000 | 0.080 | 7 | 148828812 | missense variant | C/G | snv | 7.8E-02 | 6.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.807 | 0.200 | 7 | 148811635 | missense variant | T/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.925 | 0.160 | 7 | 148811636 | missense variant | A/G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.752 | 0.200 | 7 | 148827660 | intron variant | C/T | snv | 0.80 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 |